Sanofi
Global biopharma firm researching, developing & marketing prescription medicines & vaccines.
SAN | PA
Overview
Corporate Details
- ISIN(s):
- FR0000120578 (+39 more)
- LEI:
- 549300E9PC51EN656011
- Country:
- France
- Address:
- 46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Sanofi is a global biopharmaceutical company engaged in the research, development, manufacturing, and marketing of therapeutic solutions, primarily prescription medicines and vaccines. The company leverages science and digital technologies, including AI, to discover and deliver treatments across various healthcare areas. With a worldwide presence, Sanofi operates through multiple divisions and specialized R&D-focused subsidiaries like Ablynx, Kymab, and Principia to advance its pipeline. It aims to transform the practice of medicine and improve public health by providing innovative healthcare products to millions of people globally. The company also manufactures and supplies active pharmaceutical ingredients through its Sanofi Active Ingredient Solutions arm.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-24 18:30 |
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
|
English | 12.4 MB | ||
| 2025-11-24 18:30 |
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
|
English | 12.4 MB | ||
| 2025-11-13 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Information concerning the total number of voting rights and shares – O…
|
English | 141.5 KB | ||
| 2025-11-13 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Sanofi: Informations relatives au nombre de droits de vote et d'actions – Octob…
|
French | 117.1 KB | ||
| 2025-11-03 18:30 |
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
|
French | 10.8 MB | ||
| 2025-11-03 18:30 |
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
|
English | 10.8 MB | ||
| 2025-10-31 18:30 |
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres - Revised
|
French | 9.1 MB | ||
| 2025-10-31 18:30 |
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares - Revised
|
English | 9.1 MB | ||
| 2025-10-27 18:30 |
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
|
French | 9.1 MB | ||
| 2025-10-24 07:30 |
ISS
Communiqué de presse : T3 : croissance continue du chiffre d’affaires et du bén…
|
French | 574.1 KB | ||
| 2025-10-24 07:30 |
Earnings Release
Press release: Q3: continued sales and earnings progress
|
English | 376.4 KB | ||
| 2025-10-20 18:30 |
Transaction in Own Shares
Sanofi: Disclosure of trading in own shares
|
English | 9.3 MB | ||
| 2025-10-20 18:30 |
Transaction in Own Shares
Sanofi : Déclaration des transactions sur actions propres
|
French | 9.3 MB | ||
| 2025-10-20 13:30 |
Regulatory News Service
Communiqué de presse : L’autorisation de Sanofi pour Tzield a été acceptée aux …
|
French | 183.4 KB | ||
| 2025-10-20 13:30 |
Regulatory News Service
Press Release: Sanofi’s Tzield accepted for expedited review in the US for stag…
|
English | 176.6 KB |
Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sanofi
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sanofi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-02 | N/A | Other | Buy | 71,423 | N/A |
| 2024-04-26 | N/A | Other | Buy | 1,000 | 91,380.00 EUR |
| 2023-06-09 | N/A | Other | Buy | 9 | 856.04 EUR |
| 2023-05-02 | N/A | Other | Buy | 65,205 | 6,364,008.00 EUR |
| 2023-05-02 | N/A | Other | Buy | 500 | 48,835.00 EUR |
Peer Companies
